Contact — Safe Tirzepatide

Get in touch

Safe Tirzepatide is an independent editorial project. We welcome messages on the following topics:

Citation corrections or updates — If you have identified a citation error, a broken DOI, or a more recent publication that supersedes a claim on this site, we want to know. This is how the digest stays accurate. Please include the page, the claim, and the suggested correction or replacement citation.

Editorial feedback — If a passage is unclear, jargon-heavy without adequate glossing, or otherwise difficult to read, that is useful to hear. The goal is a research digest that a curious non-specialist can navigate.

New research — If a 2024–2025 tirzepatide study, meta-analysis, or pharmacovigilance report should be indexed on this site and is not yet covered, feel free to flag it with the citation details.

What we do not handle: medical or clinical questions, requests for prescriptions or sourcing guidance, commercial inquiries, or link-exchange requests. This site does not provide medical advice.

A note on medical questions

We are an editorial publisher, not a healthcare provider. If you have questions about whether tirzepatide is appropriate for you, dosing, or management of side effects, those questions belong with a licensed healthcare provider who can review your full medical history. This site documents the published research record; it cannot and does not substitute for clinical evaluation.